CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco.
David Levison, the company’s President and Chief Executive Officer, will provide an overview of CardioDx and of Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease, on Thursday, January 10, 2013 at 10:00 a.m. PT at the Westin St. Francis Hotel.
